Enhancing Anti-Cancer Properties of Human Natural Killer Cells
Year: 2021
Type: dissertation
Abstract: Immunotherapy has revolutionized cancer treatment. Certain immunotherapies, such as immune checkpoint inhibitors and CAR-T cell therapy, provide long lasting remissions. Unfortunately, the majority of tumors are unresponsive to immunotherapy and tumors that initially respond frequently develop resistance. In order to improve patient clinical outcomes a greater understanding of anti-tumor immunology is required to broaden and refine immunotherapy treatment. While there are two types of cytotoxic lymphocytes that kill malignant cells, CD8+ T cells and natural killer (NK) cells, NK cells are under-studied in comparison to CD8+ T cells. In this dissertation, I explore multiple ways to enhance NK cell anti-cancer properties.
Author: Allison A. Fitzgerald
Institution: Georgetown University
Language: English
Subfield: Immunology
Field: Immunology and Microbiology
Domain: Life Sciences
Open Access status: green
OpenAlex ID: W3201114565
